NO953892D0 - Imidazoloquinoxalinone derivatives as EAA antagonists - Google Patents

Imidazoloquinoxalinone derivatives as EAA antagonists

Info

Publication number
NO953892D0
NO953892D0 NO953892A NO953892A NO953892D0 NO 953892 D0 NO953892 D0 NO 953892D0 NO 953892 A NO953892 A NO 953892A NO 953892 A NO953892 A NO 953892A NO 953892 D0 NO953892 D0 NO 953892D0
Authority
NO
Norway
Prior art keywords
imidazoloquinoxalinone
derivatives
preparation
eaa antagonists
eaa
Prior art date
Application number
NO953892A
Other languages
Norwegian (no)
Other versions
NO953892L (en
Inventor
Hans-Joerg Treiber
Berthold Behl
Hans Peter Hofmann
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4329970A external-priority patent/DE4329970A1/en
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO953892D0 publication Critical patent/NO953892D0/en
Publication of NO953892L publication Critical patent/NO953892L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Abstract

Described are imidazoloquinoxalinones of the formula (I) in which A and R1 to R6 are as defined in the description, plus their preparation. The compounds described can be used in the preparation of drugs for use in the treatment of neurodegenerative ailments and neurotoxic disorders of the central nervous system as well as in the preparation of spasmolytics, anti-epileptics, anxiolytics and anti-depressants.
NO953892A 1993-03-31 1995-09-29 Imidazoloquinoxalinone derivatives as EAA antagonists NO953892L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4310521 1993-03-31
DE4329970A DE4329970A1 (en) 1993-03-31 1993-09-04 New imidazolo-quinoxalinones, their manufacture and use
PCT/EP1994/000871 WO1994022865A1 (en) 1993-03-31 1994-03-19 Imidazoloquinoxalinone derivatives as eaa antagonists

Publications (2)

Publication Number Publication Date
NO953892D0 true NO953892D0 (en) 1995-09-29
NO953892L NO953892L (en) 1995-09-29

Family

ID=25924528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953892A NO953892L (en) 1993-03-31 1995-09-29 Imidazoloquinoxalinone derivatives as EAA antagonists

Country Status (17)

Country Link
EP (1) EP0691970B1 (en)
JP (1) JPH08508271A (en)
CN (1) CN1041928C (en)
AT (1) ATE173263T1 (en)
AU (1) AU6428294A (en)
BR (1) BR9406034A (en)
CA (1) CA2158167A1 (en)
CZ (1) CZ246495A3 (en)
FI (1) FI954614A0 (en)
HR (1) HRP940210A2 (en)
HU (1) HUT73970A (en)
IL (1) IL109076A (en)
NO (1) NO953892L (en)
NZ (1) NZ263552A (en)
PL (1) PL310950A1 (en)
SI (1) SI9420023A (en)
WO (1) WO1994022865A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE214069T1 (en) * 1994-02-11 2002-03-15 Novo Nordisk As HETEROCYCLIC COMPOUNDS AND THEIR PRODUCTION AND USE
FR2722789B1 (en) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa IMIDAZO (1,2-A) INDENO (1,2-E) PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM
IT1276167B1 (en) * 1995-11-24 1997-10-27 Foscama Biomed Chim Farma IMIDAZO (1,2-ALPHA) QUINOSSALIN-4-AMINE ACTIVE AS ADENOSINE ANTAGONISTS, PROCEDURE FOR THEIR PREPARATION AND COMPOSITIONS
FR2743363A1 (en) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5H, 10H-IMIDAZO (1,2-A) INDENO (1,2-E) PYRAZINE-A-ONES SUBSTITUTED IN POSITION 2, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM
US6271418B1 (en) * 2000-02-22 2001-08-07 Nippon Kayaku Co., Ltd. Process for preparing (hetero) aromatic substituted benzene derivatives
GB0017518D0 (en) * 2000-07-17 2000-08-30 Merck Sharp & Dohme Therapeutic agents
GB0018473D0 (en) 2000-07-27 2000-09-13 Merck Sharp & Dohme Therapeutic agents
CN100386326C (en) * 2003-10-22 2008-05-07 中国人民解放军军事医学科学院毒物药物研究所 1-methylolimidazole [1,2-alpha] quinoxaline compound and its application
US8299080B2 (en) * 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
FR2921927B1 (en) * 2007-10-03 2012-10-12 Univ De Montpellier 1 IMIDAZO® 1,2-A! QUINOXALINS AND DERIVATIVES FOR THE TREATMENT OF CANCER

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2043064B (en) * 1979-02-09 1983-04-13 Roussel Lab Ltd Oximidazoquinoxaline derivatives
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands

Also Published As

Publication number Publication date
CZ246495A3 (en) 1996-03-13
CN1120336A (en) 1996-04-10
EP0691970A1 (en) 1996-01-17
CN1041928C (en) 1999-02-03
FI954614A (en) 1995-09-28
EP0691970B1 (en) 1998-11-11
NZ263552A (en) 1997-06-24
AU6428294A (en) 1994-10-24
BR9406034A (en) 1996-01-02
HU9502848D0 (en) 1995-11-28
WO1994022865A1 (en) 1994-10-13
CA2158167A1 (en) 1994-10-13
ATE173263T1 (en) 1998-11-15
HRP940210A2 (en) 1996-12-31
SI9420023A (en) 1996-04-30
FI954614A0 (en) 1995-09-28
IL109076A (en) 1997-06-10
JPH08508271A (en) 1996-09-03
NO953892L (en) 1995-09-29
PL310950A1 (en) 1996-01-08
IL109076A0 (en) 1994-06-24
HUT73970A (en) 1996-10-28

Similar Documents

Publication Publication Date Title
ATE203019T1 (en) NEW (R)-5-CARBAMOYL-8-FLUORINE-3-N,N-DISUBSTITUTED-AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANES
FI924847A (en) 2-methylene-KROMANER
NO20050807L (en) Pharmaceutical compositions including dextromethorphan and quinidine for the treatment of neurological disorders
DK0668863T3 (en) Quinuclidine derivative as substance P antagonist
GR3019450T3 (en) Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
DK0751939T5 (en) Naphthylamides as central nervous system agents
DK0713701T3 (en) 2-Bromelatonin for the treatment of sleep disorders
DE68901961T2 (en) 3- (AMINOPROPYL) METHYL PHOSPHINIC ACID AS A THERAPEUTIC AGENT.
DK0687176T3 (en) Use of riluzole for the treatment of AIDS-related nervous disorders
SE9702564D0 (en) New compounds
DK0520200T3 (en) Imadazole compounds, their preparation and use
FI954614A (en) Imidazoloquinoxaline derivatives as EAA antagonists
ATE381533T1 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF THEIR USE
BR9803385A (en) Atropisomers of 2,3-disubstituted- (5,6) -heteroaryl condensate-pyrimidin-4-ones.
HUP0100611A2 (en) Triazine compounds for treatment of cns disorders
ES2124861T3 (en) AMINO ACID DERIVATIVES AND THEIR USE AS ENCEPHALINASE INHIBITORS.
NO982863L (en) New compounds with analgesic effect
ES2089286T3 (en) NEW 2-AMINO-5-CIANO-1,4-DIHIDROPIRIDINAS, PROCEDURE FOR ITS PREPARATION AND USE IN MEDICINES.
TR199901385T2 (en) Piperidin t�revleri.
PT889044E (en) DERIVATIVES OF 5- (HETEROARIL) ALTAL-3-OXO-PYRID- (1,2-A) BENZIMIDAZOLE-4-CARBOXAMIDE (GDP) USEFUL IN TREATING PERTURBACTIONS OF THE CENTRAL NERVOUS SYSTEM
FR2757512B1 (en) USE OF BENZOYLALKYL-1-1,2,3,6-TETRAHYDROPYRIDINES
TR200000916T2 (en) Substituted piperidine derivatives.